Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients
Figure 2
There was no significant relation between sustained virological response rate and age. The patients older than 65 years had hemoglobin levels similar to those aged ≤65 years.
